<http://www.ncbi.nlm.nih.gov/PubMed/>

The N-methyl-D-aspartate receptor channel blocker amantadine does not cause
histopathological alterations in human brain tissue.
PMID: 10412804; UI: 99339149.

Ethical Aspects of Neural Tissue Transplantation.
PMID: 10411958.

Nicotinic Acetylcholine Receptor Agonist SIB-1508Y Improves Cognitive
Functioning in Chronic Low-Dose MPTP-Treated Monkeys.
PMID: 10411585.

Increased brain-derived neurotrophic factor-containing axons in the basal
ganglia of patients with multiple system atrophy.
PMID: 10411346; UI: 99337153.

The need for phase III studies in experimental surgical treatments of PD
PMID: 10410785; UI: 99338974.

The case for neural tissue transplantation as a treatment for PD
PMID: 10410784; UI: 99338973.

Effect of long-term stimulation of the ventral intermediate thalamic
nucleus on gait in PD
PMID: 10410781; UI: 99338970.

Long-term electrostimulation of the ventroposterolateral pallidum in the
treatment of PD
PMID: 10410780; UI: 99338969.

Surgical treatment of levodopa-induced dyskinesias.
PMID: 10410777; UI: 99338966.

Image-guided electrophysiologically controlled posteroventral pallidotomy
for the treatment of PD: a 28-case analysis.
PMID: 10410775; UI: 99338964.

Posteroventral medial pallidotomy in advanced PD
PMID: 10410774; UI: 99338963.

Traditional and complementary therapies in PD
PMID: 10410773; UI: 99338962.

Pragmatic physical therapy in PD: any scientific basis?
PMID: 10410772; UI: 99338961.

Interdisciplinary rehabilitation in PD
PMID: 10410771; UI: 99338960.

Effects of long-term, continuous subcutaneous apomorphine infusions on
motor complications in advanced PD
PMID: 10410769; UI: 99338958.

Future delivery systems for apomorphine in patients with PD
PMID: 10410768; UI: 99338957.

Combined and selective monoamine oxidase inhibition in the treatment of
depression in PD
PMID: 10410764; UI: 99338953.

Evidence suggesting the role of norepinephrine deficiency in late stages of PD
PMID: 10410763; UI: 99338952.

COMT inhibition with entacapone in the treatment of PD
PMID: 10410761; UI: 99338950.

Do we need more drugs to treat PD?
PMID: 10410759; UI: 99338948.

Art and PD
PMID: 10410758; UI: 99338947.

Notable europeans with PD
PMID: 10410757; UI: 99338946.

Objective assessment in PD: optoelectronic movement and force analysis in
clinical routine and research.
PMID: 10410755; UI: 99338944.

Standardized quantitative measurements in PD
PMID: 10410753; UI: 99338942.

Evaluating community-based PD nurse specialists: rationale, methodology,
and representativeness of patient sample in a large randomized controlled
trial.
PMID: 10410752; UI: 99338941.

Hallucinations in PD: the clinical syndrome.
PMID: 10410750; UI: 99338939.

Clinicopathological heterogeneity and non-dopaminergic influences on
behavior in PD
PMID: 10410749; UI: 99338938.

The place of dementia in PD: a methodologic saga.
PMID: 10410748; UI: 99338937.

Psychosis and hallucinations in PD
PMID: 10410747; UI: 99338936.

Visual and visual cognitive dysfunction in PD: spatial and chromatic vision.
PMID: 10410745; UI: 99338934.

Separating the primary autonomic failure syndromes, multiple system
atrophy, and pure autonomic failure from PD
PMID: 10410741; UI: 99338930.

Urinary and anorectal function evaluation in PD
PMID: 10410740; UI: 99338929.

Preclinical diagnosis of PD
PMID: 10410737; UI: 99338926.

Apomorphine, a dopamine receptor agonist with remarkable antioxidant and
cytoprotective properties.
PMID: 10410734; UI: 99338923.

P450 and heme oxygenase enzymes in the basal ganglia and their roles in PD
PMID: 10410732; UI: 99338921.

Oxidative stress and neuroprotection in PD: implications from studies on
dopamine-induced apoptosis.
PMID: 10410731; UI: 99338920.

N-methyl(R)salsolinol, a dopamine neurotoxin, in PD
PMID: 10410730; UI: 99338919.

Nitric oxide in the pathogenesis of PD
PMID: 10410728; UI: 99338917.

Mitochondrial DNA in PD
PMID: 10410727; UI: 99338916.

Etiology of PD: contributions from 18F-DOPA positron emission tomography.
PMID: 10410726; UI: 99338915.

Time sequences of dopaminergic cell death in PD: indications for
neuroprotective studies.
PMID: 10410725; UI: 99338914.

Idiopathic PD: a genetic and environmental model.
PMID: 10410724; UI: 99338913.

Toxins, genetics, and PD: the role of N-acetyltransferase 2.
PMID: 10410722; UI: 99338911.

Clinical genetic study of familial PD in Italy.
PMID: 10410719; UI: 99338908.

Genetic and environmental factors in the pathogenesis of PD
PMID: 10410718; UI: 99338907.

The Contursi kindred, a large family with autosomal dominant PD:
implications of clinical and molecular studies.
PMID: 10410717; UI: 99338906.

Genetic and environmental factors in PD
PMID: 10410716; UI: 99338905.

Epidemiology of PD
PMID: 10410715; UI: 99338904.

Is PD an inherited condition?
PMID: 10410714; UI: 99338903.

Neurotrophins and cytokines in PD
PMID: 10410713; UI: 99338902.

Adenosine receptor antagonists and PD: actions of the A2A receptor in the
striatum.
PMID: 10410709; UI: 99338898.

The metabolic landscape of PD
PMID: 10410706; UI: 99338895.

Functional consequences of dopaminergic degeneration in PD
PMID: 10410704; UI: 99338893.

The cognitive neuropsychology of PD: a functional neuroimaging perspective.
PMID: 10410702; UI: 99338891.

Pathophysiology of the motor cortex in patients with PD
PMID: 10410699; UI: 99338888.

Neurotrophins in the pathogenesis and potential treatment of PD
PMID: 10410698; UI: 99338887.

Glial cell participation in the degeneration of dopaminergic neurons in PD
PMID: 10410697; UI: 99338886.

Engineering neurons to treat PD
PMID: 10409380.

Engineering neurons for PD
PMID: 10409349.

Acute hypernatremia and neuroleptic malignant syndrome in PD
PMID: 10408764; UI: 99335249.

Does levodopa accelerate PD?
PMID: 10408739; UI: 99335224.

Verbal memory in non-demented patients with idiopathic PD
PMID: 10408649; UI: 99335134.

Slowing of reaction time in PD: the involvement of the frontal lobes.
PMID: 10408646; UI: 99335131.

Effects of intrasubthalamic injection of dopamine receptor agonists on
subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an
electrophysiological and c-Fos study.
PMID: 10408602; UI: 99335087.

Chronic subthalamic nucleus stimulation reduces medication requirements in PD
PMID: 10408541; UI: 99335026.

Nigral endothelial dysfunction, homocysteine, and PD
PMID: 10408491; UI: 99334976.

Event-related potentials reveal memory deficits in PD
PMID: 10407205.

Regulation of parkinsonian speech volume: the effect of interlocuter
distance.
PMID: 10406989.

123I-metaiodobenzylguanidine myocardial scintigraphy in PD
PMID: 10406987.

Detection of preclinical PD in at-risk family members with use of
[123I]beta-CIT and SPECT: an exploratory study.
PMID: 10405696; UI: 99334168.

Quantification and visualization of defects of the functional dopaminergic
system using an automatic algorithm.
PMID: 10405125; UI: 99332011.

A therapeutic role for melatonin antagonism in experimental models of PD
PMID: 10405106; UI: 99331992.

New and emerging therapies for PD
PMID: 10404979; UI: 99331865.

Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing
neural stem cells by type 1 astrocytes.
PMID: 10404157.

A linear endothelin-1 analogue: solution structure of ET-1[Aib1,3,11,15,
Nle7] by nuclear magnetic resonance spectroscopy and molecular modelling.
PMID: 10403428; UI: 99330222.

Differential regulation of glutamate, aspartate and gamma-amino-butyrate
release by N-methyl-D-aspartate receptors in rat striatum after partial and
extensive lesions to the nigro-striatal dopamine pathway.
PMID: 10403427; UI: 99330221.

Motor learning by imagery is differentially affected in Parkinson's and
Huntington's diseases.
PMID: 10403020; UI: 99331452.

Distribution of the catecholaminergic neurons in the central nervous system
of human embryos and fetuses.
PMID: 10402270; UI: 99330523.

Parvocellular and magnocellular visual processing in spinocerebellar
degeneration and PD: an event-related potential study.
PMID: 10402092; UI: 99328542.

PD and lower limb somatosensory evoked potentials: apomorphine-induced
relief of the akinetic-rigid syndrome and vertex P37-N50 potentials.
PMID: 10402029; UI: 99328456.

R- and S-salsolinol are not increased in cerebrospinal fluid of
Parkinsonian patients.
PMID: 10402028; UI: 99328455.

Visual event-related potential changes at two different tasks in
nondemented PD
PMID: 10402025; UI: 99328452.

SSRI-induced parkinsonism may be an early sign of future PD
PMID: 10401924; UI: 99328351.

Function of the cerebellum in Parkinsonian rest tremor and Holmes' tremor.
PMID: 10401791; UI: 99328218.

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in
striatal neurons in PD
PMID: 10401786; UI: 99328213.

Positron emission tomographic measurement of acetylcholinesterase activity
reveals differential loss of ascending cholinergic systems in PD and
progressive supranuclear palsy.
PMID: 10401781; UI: 99328208.

Neuronal activity in the basal ganglia in patients with generalized
dystonia and hemiballismus.
PMID: 10401777; UI: 99328204.

Can calcium antagonists provide a neuroprotective effect in PD?
PMID: 10400399; UI: 99325986.

Tremor-frequency (3-6 Hz) activity in the sensorimotor arm representation
of the internal segment of the globus pallidus in patients with PD
PMID: 10400229; UI: 99325816.


janet paterson
52 now / 41 dx / 37 onset
snail-mail: PO Box 171  Almonte  Ontario  K0A 1A0  Canada
website: a new voice <http://www.geocities.com/SoHo/Village/6263/>
e-mail: <[log in to unmask]>